Cardio Diagnostics Holdings Inc Capital Reinvestment Ratio

Latest as of December 2020: 1.16x

Cardio Diagnostics Holdings Inc capital reinvestment ratio. Cardio Diagnostics Holdings Inc (CDIO) has a Capital Reinvestment Ratio of 1.16x as of December 2020, meaning it reinvests 1% of its operating cash flow ($25.86K) in capital expenditures ($29.91K). Check CDIO cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

1.16x
Capex / Operating Cash Flow

Operating Cash Flow

$25.86K
USD

Capital Expenditures

$29.91K
USD

Data as of

Dec 2020
Most recent filing

Capital Reinvestment Ratio of Cardio Diagnostics Holdings Inc (2020–2020)

Capital reinvestment ratio of Cardio Diagnostics Holdings Inc from 2020 to 2020. This chart tracks Cardio Diagnostics Holdings Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore Cardio Diagnostics Holdings Inc annual equity growth to track the company's year-over-year net asset growth rate.

Cardio Diagnostics Holdings Inc Capital Reinvestment Ratio by Year (2020–2020)

Cardio Diagnostics Holdings Inc capital reinvestment ratio by year from 2020 to 2020. For the full cash flow conversion analysis, see CDIO cash flow metrics.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2020 1.16x $25.86K $29.91K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow